IL-13 anticorps (FITC)
Aperçu rapide pour IL-13 anticorps (FITC) (ABIN317139)
Antigène
Voir toutes IL-13 (IL13) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- This antibody specifically recognises interleukin-13 (IL-13).
-
Attributs du produit
- Synonyms: IL-13, NC30
-
Purification
- Purified IgG prepared by ion exchange chromatography
-
Immunogène
- Recombinant human IL-13
-
Isotype
- IgG1
-
-
-
-
Indications d'application
-
Flow Cytometry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- Tris-NaCl pH 7.4 containing 0.02 % Sodium Azide (NaN3) and 1 % Bovine Serum Albumin
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
-
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light.
Shelf life: one year from despatch. Caution: (A full Health and Safety assessment is available upon request) This product containsSodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled bytrained staff only. -
Date de péremption
- 12 months
-
-
- IL-13 (IL13) (Interleukin 13 (IL13))
-
Autre désignation
- Interleukin-13 / IL13
-
Sujet
- IL-13 is a 12.5 kDa immunoregulatory cytokine produced primarily by activated T helper type 2 (Th2) cells, and also by mast cells and NK cells. IL-13 induces the stimulation of B cell proliferation and antibody production, and studies suggest that IL-13 plays an important role in the induction of the pathophysiological features of allergic asthma, independently of Immunoglobulin E (IgE) and eosinophils.Synonyms: IL-13, NC30
-
ID gène
- 3596
-
UniProt
- P35225
-
Pathways
- Signalistation JAK/STAT, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
Antigène
-